Insurance Barriers Limit Pulmonary Rehab Access
Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.
Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
The BEST-BE observational study will track 1,000 bronchiectasis patients to measure the impact of brensocatib on pulmonary exacerbations and patient quality of life.
A UCLA Health study compared azithromycin and roflumilast in protecting against acute exacerbations of chronic obstructive pulmonary disease (AECOPD).